Contraceptives, Oral [phsu]
Endothelial [tisu]
function [phsf]
Athletes [prog]
Athletic [dora]
Amenorrhea [dsyn]
endothelial dysfunction [dsyn]
Unfavorable [qlco]
Lipid [lipd]
Profile [lbpr]
Estrogen [horm, phsu, strd]
Substitution [idcn]
Reverse [idcn]
Metabolic [ftcn]
consequences [ftcn]
Study [mnob]
Evaluate [ftcn]
effects [qlco]
Contraceptives, Oral [phsu]
Endothelial [tisu]
function [phsf]
Measured [qlco]
Flow [npop]
mediated [socb]
Dilatation [topp]
Brachial Artery [bpoc]
Lipid [lipd]
Profile [lbpr]
Blood [tisu]
Marker [clna]
Endothelial [tisu]
Activation [acty]
Inflammation [patf]
Athletes [prog]
Age [orga]
Body Mass Index [diap]
Matched Group [grup]
Young [tmco]
Endurance [fndg]
Athletes [prog]
Amenorrhea [dsyn]
N NOS [aapp, imft]
Cycle [tmco]
Athletes [prog]
N NOS [aapp, imft]
Sedentary [qlco]
N NOS [aapp, imft]
Examined [fndg]
months [tmco]
treatment [ftcn]
Low dose [qnco]
Monophasic [tmco]
Combined [qlco]
OC [gngm]
mU/g [qnco]
Ethinyl Estradiol [horm, phsu, strd]
mU/g [qnco]
Levonorgestrel [horm, phsu, strd]
Athletes [prog]
displayed [ftcn]
Lowest [qlco]
Flow [npop]
mediated [socb]
Dilatation [topp]
baseline [bodm]
Largest [qnco]
OC [gngm]
treatment [ftcn]
Flow [npop]
mediated [socb]
Dilatation [topp]
Increased [qnco]
Control Group [grup]
Athletes [prog]
Highest [qlco]
Values [qlco]
Flow [npop]
mediated [socb]
Dilatation [topp]
treatment [ftcn]
Group [idcn]
Moderate [qlco]
Unfavorable [qlco]
Lipid [lipd]
Profile [lbpr]
Previous [tmco]
Known [qlco]
effects [qlco]
Second [qnco]
Generation [tmco]
OC [gngm]
Inflammatory [ftcn]
Marker [clna]
Sensitive [ftcn]
C-reactive protein [aapp, imft]
tnf alpha [aapp, imft]
Decrease [qlco]
Marker [clna]
Vascular Cell Adhesion Molecule-1 [aapp, imft]
conclude [bodm, orch]
Athletes [prog]
Benefit [qnco]
treatment [ftcn]
OC [gngm]
Endothelial [tisu]
function [phsf]
OC [gngm]
treatment [ftcn]
Alteration [idcn]
Lipid [lipd]
Profile [lbpr]
Marker [clna]
Inflammation [patf]
